Clinical Trial Update: Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating the effects of rimonabant on walking abilities in individuals with incomplete spinal cord injury has completed Phase 1 and Phase 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incomplete Spinal Cord Injury
• Spinal Cord Injury

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Hospital Nacional de Parapléjicos de Toledo | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED